Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 22 | 17 | −5 |
| Shares | 2.71M | 2.45M | −262.2K (−9.7%) |
| Value | $5.62M | $5.89M | +$273.0K (+4.9%) |
New holders (0)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (5)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Berkshire Asset Management LLC | 189,048 | $392.0K |
| Sterling Financial Planning, Inc. | 22,031 | $46.0K |
| Millennium Management LLC | 10,835 | $22.0K |
| UBS Group AG | 3,783 | $8.00K |
| Bank of America Corp | 579 | $1.00K |